Focal therapy for localized prostate cancer: Where do we stand?

Bruno Nahar; Dipen J Parekh

doi:10.1016/j.euf.2019.04.012

Back

Focal therapy for localized prostate cancer: Where do we stand?

Journal article

Peer reviewed

Focal therapy for localized prostate cancer: Where do we stand?

Bruno Nahar and Dipen J Parekh

European urology focus, Vol.6(2), pp.208-211

2020-03-15

DOI: https://doi.org/10.1016/j.euf.2019.04.012

PMID: 31053567

Abstract

Prostatic Neoplasms - pathology

Ablation Techniques

Male

Prostatic Neoplasms - surgery

Humans

Focal therapy for localized prostate cancer has emerged as an alternative to whole-gland treatment given its superior side-effects profile and acceptable short-term cancer control. Here we summarize the most relevant evidence related to each focal therapy modality.

Metrics

6 Record Views

5 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.147 Prostate Cancer; 1.147.97 Prostate Cancer
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Focal therapy for localized prostate cancer: Where do we stand?
Creators: Bruno Nahar - Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: brunonahar@miami.edu
Dipen J Parekh - Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
Publication Details: European urology focus, Vol.6(2), pp.208-211
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Urology
Language: English
Resource Type: Journal article
PMID: 31053567
Record Identifier: 991031597632202976